TABLE 6.
Treatment Modalities in Children with ARP and CP by BMI Status
| Underweight (n = 22) | Normal (n = 258) | Overweight (n = 75) | Obese (n = 91) | P* | |
|---|---|---|---|---|---|
| Medical Therapies | 11/21 (52) | 133/248 (54) | 29/74 (39) | 32/90 (36) | <0.001 |
| Pain medications | 3/15 (20) | 91/194 (47) | 16/54 (30) | 27/71 (38) | 0.07 |
| Pancreatic enzymes | 9/21 (43) | 109/248 (44) | 20/73 (27) | 26/90 (29) | 0.001 |
| Vitamins/antioxidants | 0/20 (0) | 28/242 (12) | 9/71 (13) | 8/88 (9) | 0.99 |
| Steroids | 0/21 (0) | 6/239 (3) | 1/72 (1) | 2/84 (2) | 0.96 |
| Octreotide | 0/21 (0) | 7/245 (3) | 2/71 (3) | 0/87 (0) | 0.34 |
| Endoscopic Therapies | 10/21 (48) | 116/251 (46) | 24/73 (33) | 31/88 (35) | 0.01 |
| Biliary sphincterotomy | 4/21 (19) | 43/246 (17) | 7/71 (10) | 17/88 (19) | 0.57 |
| Pancreatic duct stent | 5/21 (24) | 58/245 (24) | 15/72 (21) | 15/88 (17) | 0.21 |
| Biliary stent | 3/21 (14) | 10/247 (4) | 2/71 (3) | 3/88 (3) | 0.35 |
| Pancreatic duct stone removal | 3/20 (15) | 32/248 (13) | 5/71 (7) | 9/88 (10) | 0.19 |
| Surgical Therapies | 6/21 (29) | 66/255 (26) | 14/72 (19) | 17/89 (19) | 0.10 |
| Cholecystectomy | 4/21 (19) | 36/255 (14) | 8/72 (11) | 11/88 (12) | 0.44 |
| Celiac nerve block | 0/21 (0) | 4/255 (2) | 0/71 (4) | 1/89 (1) | 0.65 |
| Cyst/pseudo-cyst operation | 0/21 (0) | 10/255 (4) | 3/71 (4) | 2/89 (2) | 0.76 |
| Lateral pancreaticojejonstomy | 0/21 (0) | 11/255 (4) | 0/71 (0) | 3/89 (3) | 0.31 |
| Partial pancreatectomy | 0/21 (0) | 2/255 (1) | 2/71 (3) | 0/89 (0) | 0.82 |
| TPIAT | 2/21 (10) | 34/255 (13) | 2/71 (3) | 4/88 (5) | 0.002 |
Denominators represent data available for each group; data expressed as n (%) unless otherwise specified.
Statistically significant values are in bold.
*
Cochran-Armitage trend test was used for statistical comparisons.
ARP indicates Acute Recurrent Pancreatitis; CP, Chronic Pancreatitis; TPIAT, Total pancreatectomy/islet autotransplantation.